Propanc Biopharma (PPCB) Total Debt (2011 - 2026)
Propanc Biopharma (PPCB) recorded Total Debt of $460,809 in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 61.2% from $1.19 million a year earlier.
Powered by 
Analysis
Propanc Biopharma (PPCB) Total Debt (2011 - 2026) Analysis & Trends
Starting with fiscal Q2 2012, Propanc Biopharma's Total Debt history includes 53 quarters.
- Annual Total Debt has a five-year compound annual growth rate of -5.9% (FY2021 to FY2026).
- Across earlier fiscal years, Total Debt came in at $1.19 million in FY2025 (+79.1%), $662,661 in FY2024 (+45.4%), $455,819 in FY2023 (-52.4%) and $957,184 in FY2022 (+53.3%).
- Quarterly Total Debt has ranged from $120,280 in fiscal Q2 2026 to $1.19 million in fiscal Q4 2025 over the past five years.
- On a year-over-year basis, Total Debt rose in three of the last seven quarters, with an average decline of 16.7%.
- Peak year-over-year performance for Total Debt in the last five years was growth of 79.1% in fiscal Q4 2025, against a decline of 83.4% in fiscal Q2 2026 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 49.04 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 37.49 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -111.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 57.30 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 26.25 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 63.19 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Propanc Biopharma | 595,565.74 | 595,565.74 | - | 460,809.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 460,809.00 |
| Dec 31, 2025 | 120,280.00 |
| Sep 30, 2025 | 172,248.00 |
| Jun 30, 2025 | 1.19 Mn |
| Mar 31, 2025 | 813,999.00 |
| Dec 31, 2024 | 723,107.00 |
| Sep 30, 2024 | 739,989.00 |
| Jun 30, 2024 | 662,661.00 |
| Mar 31, 2024 | 763,169.00 |
| Dec 31, 2023 | 854,864.00 |
| Sep 30, 2023 | 552,024.00 |
| Jun 30, 2023 | 455,819.00 |
| Mar 31, 2023 | 569,276.00 |
| Dec 31, 2022 | 756,501.00 |
| Sep 30, 2022 | 913,641.00 |
| Jun 30, 2022 | 957,184.00 |
| Mar 31, 2022 | 1.08 Mn |
| Dec 31, 2021 | 972,670.00 |
| Sep 30, 2021 | 584,608.00 |
| Jun 30, 2021 | 624,583.00 |
API Access
Propanc Biopharma Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();